City of Hope, one of only 57 National Cancer Institute-designated Comprehensive Cancer Centers in the U.S., is dedicated solely to cancer care, with over 550 physicians and 1,000 researchers across an integrated national network. Known for pioneering treatments, City of Hope has achieved breakthroughs in therapies, including CAR T-cell treatments for prostate and brain cancers and biotherapeutics for immunotherapy enhancement. It runs one of the nation’s largest bone marrow transplant programs, with nearly 19,000 transplants performed to date, and conducts more than 850 clinical trials annually. Recent advancements include a novel lung cancer liquid biopsy test and a pancreatic cancer detection test with high accuracy for early-stage cancers. City of Hope also launched a mobile cancer screening program to increase community access to preventive care and is ranked among the top five cancer care providers in the U.S. by U.S. News & World Report.
